
A clinical laboratory receives a new lot of PTT reagent,so clinical laboratory scientists in the laboratory need to establish the heparin therapeutic range for this new reagent lot.How should this be done?
A) Compare PTT results for patient heparinized samples to those for the lot of PTT reagent that is presently being used.
B) Perform chromogenic Xa and PTT assays on patient heparinized samples, and do a statistical analysis of result comparisons.
C) Add heparin at various therapeutic concentrations to normal plasma, and perform PTT on each concentration using the new lot of reagent.
D) Add heparin at high concentration to one normal plasma, make dilutions of this plasma, and then perform PTT on each diluted sample using the new lot of reagent.
Correct Answer:
Verified
Q7: Direct thrombin inhibitors include lepirudin and argatroban;they
A)require
Q8: Why is the platelet count monitored daily
Q9: Which of the following is true related
Q10: A patient is admitted through the hospital
Q11: A patient is stabilized on warfarin therapy
Q12: Unfractionated heparin is commonly monitored by the
A)PT.
B)partial
Q14: Once a patient is stabilized on warfarin
Q15: Elevated urinary levels of 11-dehydrothromboxane B₂ identify
Q16: Warfarin skin necrosis occurs within the first
Q17: Why is it important to monitor patients
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents